glp-1 generics Looming drug patent expirations draw firms Diabetes patients have access to

Key points Real-world studies show high discontinuation rates for glucagon-like peptide 1 receptor agonists (GLP1RAs) and tirzepatide, particularly among individuals without type 2 diabetes mellitus who are using these drugs to treat obesity

Cholesterol and triglycerides often decrease, supporting cardiovascular health

This can improve insulin sensitivity and metabolic health, which can make pregnancy more likely over time

Always verify vial vacuum and seal integrity before laboratory use

81430098), the National Key R&D Program of China (2018YFC1704901) and the Beijing Natural Science Foundation (No.7172185)

Peptide Shop supplies DSIP 5 mg as a sealed research material with lot-level documentation where available